Respiratory Medicine
Volume 103, Issue 9 , Pages 1346-1349 , September 2009

The prevalence of coronary artery disease in end-stage pulmonary disease: Is pulmonary fibrosis a risk factor?

  • Gabriel Izbicki

      Affiliations

    • Pulmonary Institute, Shaare Zedek Medical Center, Jerusalem and the Hebrew University-Hadassah Medical School, P.O. Box 3235, Jerusalem 91031, Israel
    • Corresponding Author InformationCorresponding author: Tel.: +972 2 6666278; fax: +972 2 6666772.
    • ,
  • Itsik Ben-Dor

      Affiliations

    • Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petach Tiqva and Sackler Faculty of Medicine, Tel-Aviv University, Petah Tiqva 49100, Israel
    • ,
  • David Shitrit

      Affiliations

    • Institute of Pulmonology, Rabin Medical Center, Beilinson Campus, Petach Tiqva and Sackler Faculty of Medicine, Tel-Aviv University, Petah Tiqva 49100, Israel
    • ,
  • Danielle Bendayan

      Affiliations

    • Institute of Pulmonology, Rabin Medical Center, Beilinson Campus, Petach Tiqva and Sackler Faculty of Medicine, Tel-Aviv University, Petah Tiqva 49100, Israel
    • ,
  • Thomas K. Aldrich

      Affiliations

    • Pulmonary Division, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
    • ,
  • Ran Kornowski

      Affiliations

    • Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petach Tiqva and Sackler Faculty of Medicine, Tel-Aviv University, Petah Tiqva 49100, Israel
    • ,
  • Mordechai R. Kramer

      Affiliations

    • Institute of Pulmonology, Rabin Medical Center, Beilinson Campus, Petach Tiqva and Sackler Faculty of Medicine, Tel-Aviv University, Petah Tiqva 49100, Israel

Received 1 May 2008 ,Accepted 18 March 2009.

References 

  1. International guidelines for the selection of lung transplant candidates . The American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT). Am J Respir Crit Care Med. 1998;158:335–339
  2. Trulock EP, Edwards LB, Taylor DO, et al. The registry of the international society for heart and lung transplantation. J Heart Lung Transplant. 2004;23:804–815
  3. Lee R, Meyers BF, Sundt T, et al. Concomitant coronary artery revascularization to allow successful lung transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg. 2002;124:1250–1251
  4. Kizer JR, Zisman DA, Blumenthal NP, et al. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med. 2004;164:551–556
  5. Celli BR, MacNee W, ATS/ERS Task Force . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946
  6. ATS/ERS International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277–304
  7. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126
  8. Strieter RM, Keane MP, Standtford TK, Kunkel SL. Cytokine biology and the pathogenesis of interstitial lung disease. In:  Schwartz MI,  King TE editor. Interstitial lung diseases. 3rd ed.. Hamilton, Ontario: BC Decker Inc.; 1998;p. 181–205
  9. Rifai N, Joubran R, Yu H, et al. Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem. 1999;45:1967–1973
  10. Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999;100:793–798
  11. Biasucci L, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874–877
  12. Ridker P, Cushman M, Stampfer M, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  13. Ridker P, Hennekens C, Buring J, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  14. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809
  15. Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs. 2004;64:405–430
  16. Kelly M, Kolb M, Bonniaud P, Gauldie J. Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des. 2003;9:39–49
  17. Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE, et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest. 2004;125:2169–2174
  18. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2407–2415

PII: S0954-6111(09)00093-6

doi: 10.1016/j.rmed.2009.03.012

Respiratory Medicine
Volume 103, Issue 9 , Pages 1346-1349 , September 2009

Article Tools

* Image Usage & Resolution